🇺🇸 Ornidazole and Sodium Chloride Injection in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 10
Most-reported reactions
- Abdominal Discomfort — 1 report (10%)
- Anaemia — 1 report (10%)
- Atrial Fibrillation — 1 report (10%)
- Blood Albumin Decreased — 1 report (10%)
- Body Temperature Increased — 1 report (10%)
- Cyanosis — 1 report (10%)
- Electrocardiogram St Segment Abnormal — 1 report (10%)
- Extrasystoles — 1 report (10%)
- Muscle Spasms — 1 report (10%)
- Tremor — 1 report (10%)
Other Infectious Disease approved in United States
Frequently asked questions
Is Ornidazole and Sodium Chloride Injection approved in United States?
Ornidazole and Sodium Chloride Injection does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Ornidazole and Sodium Chloride Injection in United States?
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.